Core Viewpoint - WuXi Biologics has been recognized by CDP for its leadership in climate change disclosure and performance, achieving an "A-" score for the second consecutive year, highlighting its commitment to sustainability and environmental stewardship [1][2][4]. Company Achievements - WuXi Biologics has adopted an integrated strategy to address climate change, aiming for net-zero emissions by 2050 and achieving a 30% reduction in GHG emission intensity from 2020 levels in 2024 [3]. - The company has received multiple accolades for its sustainability efforts, including an MSCI AAA Rating, EcoVadis Platinum Medal, and inclusion in the Dow Jones Sustainability Indices for two consecutive years [4]. Environmental Initiatives - WuXi Biologics is committed to the Science Based Target initiative (SBTi) and actively pursues energy-saving initiatives, including process optimization and infrastructure upgrades [3]. - The company has achieved a 100% renewable electricity supply at its Ireland site and is deploying rooftop photovoltaic power projects [3]. Industry Context - CDP serves as a global standard for corporate environmental reporting, with nearly 25,000 companies reporting their environmental data in 2024, representing two-thirds of the global market value [2]. - The recognition from CDP is significant as it influences investment and procurement decisions towards a sustainable economy [2].
WuXi Biologics Recognized by CDP for Climate Change Leadership for Second Consecutive Year